Abuse of New Psychoactive Substances: Threats and Solutions

Neuropsychopharmacology

Volumn 41, Issue 3, 2016, Pages 663-665

  Baumann, Michael H ^a   Volkow, Nora D ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CONTROLLED SUBSTANCE; METHYLONE; NEW DRUG; PSYCHOTROPIC AGENT; STREET DRUG;

DRUG INTOXICATION; GOVERNMENT; HUMAN; PRIORITY JOURNAL; REVIEW; SUBSTANCE ABUSE; DRUG DEPENDENCE; DRUG LEGISLATION; HEALTH EDUCATION; INTERNET; UNITED STATES;

HEALTH EDUCATION; HUMANS; INTERNET; LEGISLATION, DRUG; PSYCHOTROPIC DRUGS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84954025632     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.260     Document Type: Review

References (6)

1. Baumann MH, Solis E, Watterson LR, Marusich JA, Fantegrossi WE, Wiley JL (2014). Bath salts, spice and related designer drugs: The science behind the headlines. J Neurosci 34: 15150-15158.
2. Brandt SD, King LA, Evans-Brown M (2014). The new drug phenomenon. Drug Test Anal 6: 587-597.
3. Drug Enforcement Administration (2014). Special report: Synthetic cannabinoids and cathinones reported in NFLIS, 2010-2013 http://www.deadiversion.usdoj.gov/nflis/spec-rpt- CathCan-2013.pdf.
4. Nutt DJ, King LA, Nichols DE (2013). Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nat Rev Neurosci 14: 577-585.
5. Trecki J, Gerona RR, Schwartz MD (2015). Synthetic cannabinoidrelated illnesses and deaths. N Engl J Med 373: 103-107.
6. United Nations Office of Drugs and Crime (2015). World Drug Report 2015 http://www.unodc.org/documents/wdr2015/World- Drug-Report-2015.pdf.